Press Release

Morgan Lewis Advises ADMA Biologics on $175M Debt Refinancing

Thursday, March 24, 2022

PHILADELPHIA, March 24, 2022: Morgan Lewis represented ADMA Biologics Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, in connection with a $175 million debt refinancing with Hayfin Capital Management.

Morgan Lewis partner Andrew Budreika, associate Ben Stango, and of counsel Kathleen Martin represented ADMA, along with associates Elise Ryan, Kevin Rajan, and Jose Robles.

For more, read the announcement.